Why a Medical Device Company Is Stacking Bitcoin Like MicroStrategy

🏥 A Medical Tech Company with a Bitcoin Fixation

Semler Scientific isn’t building blockchains. It’s building devices for early diagnosis of chronic disease.

So why did this healthcare company just buy 455 more BTC, dropping another 50 million into Bitcoin between May 13–22, 2025?

Because it sees Bitcoin as the financial medicine of the future.

And it’s not alone.

🧾 The Numbers: Bigger Stack, Bigger Bet

Here’s where they stand:

• New BTC purchase: 455 coins for 50M
• Average buy price: 109,801
• Total BTC holdings: 4,264 BTC
• Total invested: 390M
• Current value: 474M
• YTD BTC return: 25.8%

This isn’t just treasury diversification. It’s a full-blown Bitcoin strategy.

💰 Bitcoin as a Corporate Treasury Weapon

Semler began stacking sats in May 2024, becoming the second public U.S. company after MicroStrategy to adopt Bitcoin as a primary treasury reserve asset.

Their reasoning?

Bitcoin is liquid. It’s scarce. It’s programmable. And in a world of money printing, it holds its value.

They’re using proceeds from stock issuance, debt raises, and cash flow — and converting them straight into BTC. It’s a pivot from balance sheet safety to balance sheet performance.

💡 Meanwhile, the Core Business Keeps Shipping

Don’t let the BTC headlines distract you — Semler is still building in medtech.

Their star product? QuantaFlo® — an FDA-cleared diagnostic device that helps doctors detect vascular diseases like PAD (Peripheral Arterial Disease) early, even in patients without symptoms.

They’re also pushing for expanded FDA approvals to cover more use cases. That’s legit innovation in public health — now funded, in part, by crypto returns.

⚖️ The Legal Curveball

On May 22, Bragar Eagel & Squire — a U.S. law firm — launched an investigation into Semler over potential securities violations.

This came just weeks after Semler filed to raise up to 500 million in new securities with the SEC — funds earmarked for more BTC buys.

The case is developing, and shareholders have been invited to join the probe.

Whether this turns into anything big? TBD. But it shows the regulatory tension when public companies go full crypto-native.

🧠 TL;DR: Wall Street Meets Web3 in a Hospital Gown

• 🏥 Medtech firm Semler Scientific now holds 4,264 BTC worth 474M
• 💸 Latest 50M buy = 455 BTC at 109K average
• 📈 Up 26% on BTC treasury YTD
• 🏛 Facing securities probe while doubling down on Bitcoin
• ⚕️ Still pushing FDA-cleared diagnostics in chronic care

Bitcoin isn’t just for tech firms or hedge funds anymore. It’s for companies that believe money should work as hard as their products do.